RESEARCH-USE BIOSIMILAR ANTIBODY
Lupartumab
Antibody-drug conjugate · IgG1
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980 (HY-P99719).
TARGETLYPD3
YAntibody-drug conjugate
CATALOGSC-BS-396
CATALOG NUMBERSC-BS-396
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980 (HY-P99719).
Lupartumab is a recombinant research-use antibody directed against LYPD3.